| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.051 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.9 |